GDUFA Success Story: FDA Exceeds Hiring Goals, Names OGD Director
This article was originally published in The Pink Sheet Daily
Executive Summary
By mid-December, the agency had hired more than 1,000 new employees for the generic user fee program, and now adds one more to the tally – Kathleen Uhl as permanent director of the Office of Generic Drugs.
You may also be interested in...
Next US FDA Generics Leader Must Have ‘Frank Conversations’ With Colleagues, Industry, Former OGD Director Says
Susan Rosencrance, who helped negotiate GDUFA III, will take over as acting director of the Office of Generic Drugs following Sally Choe’s departure on 8 October. Former OGD head Uhl says the director needs to be the ‘number one advocate for the generic drug program inside the agency.’
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.